Simmons Jeffrey N
PRESIDENT, CEO AND DIRECTOR
Simmons Jeffrey N has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: May 19, 2026.
On the most recent filing, Simmons Jeffrey N is listed as PRESIDENT, CEO AND DIRECTOR at Elanco Animal Health Inc. Inside the rolling window, Simmons Jeffrey N reported 2 open-market purchases totaling $578K in ELAN and no open-market sales. The largest disclosed transaction in the window is a purchase of 22,000 ELAN shares on Dec 11, 2025, worth $478K.
Companies traded
Other insiders at ELAN
Insider Buying
$578K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Simmons Jeffrey N made?
Simmons Jeffrey N has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Simmons Jeffrey N trade?
Simmons Jeffrey N has filed SEC Form 4 disclosures for 1 company, including ELAN.
When was Simmons Jeffrey N's most recent SEC Form 4 filing?
Simmons Jeffrey N's most recent SEC Form 4 filing on Tracefour is dated May 19, 2026.
What is Simmons Jeffrey N's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Simmons Jeffrey N is listed as PRESIDENT, CEO AND DIRECTOR.
What is Simmons Jeffrey N's total buy and sell value in the current window?
Inside the rolling retention window, Simmons Jeffrey N bought $578K and sold $0 based on SEC Form 4 filings.
What was Simmons Jeffrey N's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 22,000 ELAN shares on 2025-12-11, worth $478K, per SEC Form 4 filings.